Order Article Reprints

Kusic D, Heil J, Zajic S, Brangan A, Dairo O, Smith G, Morales-Scheihing D, Buono RJ, Ferraro TN, Haroz R, et al. Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative. Pharmaceutics. 2022; 14(9):1863. https://doi.org/10.3390/pharmaceutics14091863

Kusic, Dara, Jessica Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Gretchen Smith, Diego Morales-Scheihing, Russell J. Buono, Thomas N. Ferraro, Rachel Haroz, and et al. 2022. "Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative" Pharmaceutics 14, no. 9: 1863. https://doi.org/10.3390/pharmaceutics14091863

Kusic, D., Heil, J., Zajic, S., Brangan, A., Dairo, O., Smith, G., Morales-Scheihing, D., Buono, R. J., Ferraro, T. N., Haroz, R., Salzman, M., Baston, K., Bodofsky, E., Sabia, M., Resch, A., & Scheinfeldt, L. B. (2022). Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative. Pharmaceutics, 14(9), 1863. https://doi.org/10.3390/pharmaceutics14091863